Quantitative assessment of H&E staining for pathology: development and clinical evaluation of a novel system.

Journal: Diagnostic pathology
PMID:

Abstract

BACKGROUND: Staining tissue samples to visualise cellular detail and tissue structure is at the core of pathology diagnosis, but variations in staining can result in significantly different appearances of the tissue sample. While the human visual system is adept at compensating for stain variation, with the growth of digital imaging in pathology, the impact of this variation can be more profound. Despite the ubiquity of haematoxylin and eosin staining in clinical practice worldwide, objective quantification is not yet available. We propose a method for quantitative haematoxylin and eosin stain assessment to facilitate quality assurance of histopathology staining, enabling truly quantitative quality control and improved standardisation.

Authors

  • Catriona Dunn
    National Pathology Imaging Co-operative, Leeds Teaching Hospitals NHS Trust, Leeds, UK. catriona.dunn@nhs.net.
  • David Brettle
    National Pathology Imaging Co-operative, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Martin Cockroft
    New Technology Group, Futamura Chemical UK Limited, Wigton, UK.
  • Elizabeth Keating
    New Technology Group, Futamura Chemical UK Limited, Wigton, UK.
  • Craig Revie
    FFEI Limited, The Cube, Hemel Hempstead, UK.
  • Darren Treanor
    Leeds Teaching Hospitals NHS Trust, Leeds, UK.